20 January 2023 in Current Pediatrics
Background. Fibrodysplasia ossificans progressiva (FOP) is a genetic disease of the heterotopic ossification group associated with the mutation in ACVR1/ALK2 gene. FOP is characterized by progressive heterotopic endochondral ossification of connective tissue that occurs in postnatal period. It leads to formation of qualitatively normal bone in extraskeletal areas. Congenital hallux deformity is typical for this disease. The clinical picture is characterized by aggravations that are usually caused by trauma or viral infections. Formation of Heterotopic ossificate formation can be observed during aggravations. There is no etiological treatment for FOP. Systemic glucocorticosteroids, non-steroidal anti-inflammatory drug (NSAIDs), mast cell stabilisers, antileukotriene drugs and bisphosphonates can be used in these patients.Clinical case description. The child was born with congenital hallux deformity typical for FOP. The disease onset was noted at the age of 2 years 8 months with a tumor-like painful mass on the neck. Oncological (lymphoproliferative) disease was suspected but biopsy from the lesion did not confirm its malignant nature. The child was consulted by pediatric rheumatologist who has diagnosed FOP. Etanercept and zoledronic acid were administrated, though etanercept was later discontinued. For now, the child receives zoledronic acid infusions 2 times per year and daily NSAIDs.Conclusion. The difficulties in FOP diagnosing are associated to its sporadic nature and clinical picture similarity to other diseases. Suspected malignancy leads to biopsy that is highly undesirable in FOP patients due to high risk of iatrogenic complications.
23 June 2019 in Current Pediatrics
Background.The prevalence of symptoms of life-threatening events in infants was previously studied using hospital data. However, not all parents in the event of such symptoms seek medical help in the hospital.Objective.Our aim was to identify the prevalence and risk factors of life-threatening events in infants in the first year of life.Methods.In the period from November 2017 to February 2018, we interviewed mothers who have children in their second year of life who are registered at children's outpatient clinics in Syktyvkar. Respondents noted episodes of absent, infrequent or irregular breathing, blanching or cyanosis of the skin, changes in muscle tone (hypo- or hypertonia), changes in the level of responses that occurred in infancy. The prevalence of symptoms of life-threatening events was estimated based on the total number of infants in the first year of life (n = 3088) who lived in Syktyvkar as of January 1, 2018.Results.At least one symptom of life-threatening events in infancy was reported by 43 (4.3%) of the 1001 mothers surveyed. The prevalence of symptoms was 429.5 [95% confidence interval (CI) 321–574] per 10,000 children of the corresponding age. Independent predictors of life-threatening events in children of the first year of life were sudden deaths of relatives under the age of 50 years [odds ratio (OR) 2.4; 95% CI 1.1–5.3], cases of pre-syncope or syncope in relatives (OR 4.4, 95% CI 2.1–9.0), artificial feeding of infants (OR 4.0, 95% CI 1.5–11.2). The sensitivity of the model, which took into account the presence of at least one of the three predictors, was 19% (8/43), specificity — 99% (2/958).Conclusion.The issue of the occurrence of life-threatening events in an infant can impact every 25th family. In every fifth infant, the occurrence of symptoms of life-threatening events can be predicted based on risk factors.
29 September 2017 in Mordovia University Bulletin
PUPitirim Sorokin Syktyvkar State University
Pitirim Sorokin Syktyvkar State University
MKMinistry of Health of the Respublic of Komi
Ministry of Health of the Respublic of Komi
GHGeneral Children Clinical Hospital
General Children Clinical Hospital
Официальный сайт журнала "Вестник Мордовского университета"
10 August 2021 in Current Pediatrics
The literature overview about the issues of sudden infant death syndrome (SIDS) is presented in the article. The emphasis is on the evolution of the diagnosis definitions, incorrect use of the “synonym” term “sudden child death syndrome” in our country. Epidemiological characteristics of SIDS in countries with different levels of per capita income are presented. Modern view on the theories of the syndrome onset is analyzed. Risk factors are analyzed from the position of influence and change, i.e. possible modification to affect the syndrome incident that is crucial for every pediatrician. SIDS protective factors as the basis of primary prevention are discussed. The algorithm for organizing safe sleep space for children to reduce the risks of infant death associated with sleep is presented. This algorithm is proposed to be used in educational programs for pregnant women and parents of infants.
15 May 2019 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
The article analyzes the literature on the development of views on the definition, approaches to diagnostics and tactical measures in case of suddenly manifesting conditions in children of the first year of life, accompanied by respiratory failure, changes in muscle tone and skin color. The article contains data from the clinical guidelines of theAmericanAcademyof Pediatrics 2016. The above guidelines gave introduced a new term “brief resolved unexplained event” (BRUE) and distinguished two groups of infants – with low and high risk of unfavorable outcome. The article contains a definition of a “life-threatening event”, which refers to events in children of the first year of life who have experienced a rapidly resolved unexplained condition and met the criteria of low risk. The authors describe the approaches to the diagnosis and prevention of pseudo-life-threatening events in infants. The authors call the pediatric community to discuss and present their own view on the problem of definition and tactical measures necessary for identifying quickly resolved unexplained events in children of the first year of life who meet the criteria of low risk.
15 December 2004 in N.N. Priorov Journal of Traumatology and Orthopedics
Results of treatment of 39 patients with hip and knee I-III osteoarthrosis are presented. Treatment consisted of irradiation of bioactive arthrospecific points with high energy Nd-laser followed by injections of drug cocktail into those points. No steroid drugs were used. The method could be used both as independent technique for rehabilitation treatment and preoperative management. It is shown that suggested method provides longer non-medicine remission as well as repeated remission in comparison with traditional conservative treatment.